These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 34908453)

  • 21. Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus.
    Kumar A; Khan IA; Koul S; Koul JL; Taneja SC; Ali I; Ali F; Sharma S; Mirza ZM; Kumar M; Sangwan PL; Gupta P; Thota N; Qazi GN
    J Antimicrob Chemother; 2008 Jun; 61(6):1270-6. PubMed ID: 18334493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
    Kumar G; Goutami Godavari A; Tambat R; Kumar S; Nandanwar H; Elizabeth Sobhia M; Jachak SM
    Bioorg Chem; 2020 Nov; 104():104225. PubMed ID: 32992278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in silico inhibitory effects of synthetic and natural eugenol derivatives against the NorA efflux pump in Staphylococcus aureus.
    Muniz DF; Dos Santos Barbosa CR; de Menezes IRA; de Sousa EO; Pereira RLS; Júnior JTC; Pereira PS; de Matos YMLS; da Costa RHS; de Morais Oliveira-Tintino CD; Coutinho HDM; Filho JMB; Ribeiro de Sousa G; Filho JR; Siqueira-Junior JP; Tintino SR
    Food Chem; 2021 Feb; 337():127776. PubMed ID: 32777574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
    Aeschlimann JR; Kaatz GW; Rybak MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
    Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
    J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity and inhibition of the NorA efflux pump of Staphylococcus aureus by extract and isolated compounds from Arrabidaea brachypoda.
    de Sousa Andrade LM; de Oliveira ABM; Leal ALAB; de Alcântara Oliveira FA; Portela AL; de Sousa Lima Neto J; de Siqueira-Júnior JP; Kaatz GW; da Rocha CQ; Barreto HM
    Microb Pathog; 2020 Mar; 140():103935. PubMed ID: 31857236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenylated isoflavonoids from Fabaceae against the NorA efflux pump in Staphylococcus aureus.
    Ika Irianti M; Vincken JP; van Dinteren S; Ter Beest E; Pos KM; Araya-Cloutier C
    Sci Rep; 2023 Dec; 13(1):22548. PubMed ID: 38110428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
    Deka B; Suri M; Sarma S; Devi MV; Bora A; Sen T; Dihingia A; Pahari P; Singh AK
    Bioorg Med Chem; 2022 Jan; 54():116580. PubMed ID: 34953341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-antibiotic agent ginsenoside 20(S)-Rh2 enhanced the antibacterial effects of ciprofloxacin in vitro and in vivo as a potential NorA inhibitor.
    Zhang J; Sun Y; Wang Y; Lu M; He J; Liu J; Chen Q; Zhang X; Zhou F; Wang G; Sun X
    Eur J Pharmacol; 2014 Oct; 740():277-84. PubMed ID: 25054686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial activity of Phyllanthus amarus Schumach. & Thonn and inhibition of the NorA efflux pump of Staphylococcus aureus by Phyllanthin.
    Braga Ribeiro AM; Sousa JN; Costa LM; Oliveira FAA; Dos Santos RC; Silva Nunes AS; da Silva WO; Marques Cordeiro PJ; de Sousa Lima Neto J; de Siqueira-Júnior JP; Kaatz GW; Barreto HM; de Oliveira AP
    Microb Pathog; 2019 May; 130():242-246. PubMed ID: 30876871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of expression of NorA efflux pump in ciprofloxacin resistant Staphylococcus aureus against hexahydroquinoline derivative by real-time PCR.
    Pourmand MR; Yousefi M; Salami SA; Amini M
    Acta Med Iran; 2014; 52(6):424-9. PubMed ID: 25130148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fighting Antimicrobial Resistance: Insights on How the
    Palazzotti D; Felicetti T; Sabatini S; Moro S; Barreca ML; Sturlese M; Astolfi A
    J Chem Inf Model; 2023 Aug; 63(15):4875-4887. PubMed ID: 37515548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymoquinone' potent impairment of multidrug-resistant Staphylococcus aureus NorA efflux pump activity.
    Ahmad AAM; Abdelgalil SY; Khamis T; Abdelwahab AMO; Atwa DN; Elmowalid GA
    Sci Rep; 2024 Jul; 14(1):16483. PubMed ID: 39013998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo.
    Sundaramoorthy NS; Mitra K; Ganesh JS; Makala H; Lotha R; Bhanuvalli SR; Ulaganathan V; Tiru V; Sivasubramanian A; Nagarajan S
    Microb Pathog; 2018 Nov; 124():54-62. PubMed ID: 30118803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction.
    Felicetti T; Cannalire R; Pietrella D; Latacz G; Lubelska A; Manfroni G; Barreca ML; Massari S; Tabarrini O; Kieć-Kononowicz K; Schindler BD; Kaatz GW; Cecchetti V; Sabatini S
    J Med Chem; 2018 Sep; 61(17):7827-7848. PubMed ID: 30067360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus.
    Aeschlimann JR; Dresser LD; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1999 Feb; 43(2):335-40. PubMed ID: 9925528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tackling multidrug-resistant Staphylococcus aureus by natural products and their analogues acting as NorA efflux pump inhibitors.
    Kumar G; Kiran Tudu A
    Bioorg Med Chem; 2023 Feb; 80():117187. PubMed ID: 36731248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Carvacrol and Thymol on NorA efflux pump inhibition in multidrug-resistant (MDR) Staphylococcus aureus strains.
    Dos Santos Barbosa CR; Scherf JR; de Freitas TS; de Menezes IRA; Pereira RLS; Dos Santos JFS; de Jesus SSP; Lopes TP; de Sousa Silveira Z; de Morais Oliveira-Tintino CD; Júnior JPS; Coutinho HDM; Tintino SR; da Cunha FAB
    J Bioenerg Biomembr; 2021 Aug; 53(4):489-498. PubMed ID: 34159523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel DiOC
    Elhidar N; Nafis A; Goehler A; Abbad A; Hassani L; Mezrioui NE; Bohnert JA
    J Microbiol Methods; 2021 Feb; 181():106128. PubMed ID: 33347918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
    Vidaillac C; Guillon J; Arpin C; Forfar-Bares I; Ba BB; Grellet J; Moreau S; Caignard DH; Jarry C; Quentin C
    Antimicrob Agents Chemother; 2007 Mar; 51(3):831-8. PubMed ID: 17101679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.